Jump to content

Mervyn Maze

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Macbflo (talk | contribs) at 03:17, 16 June 2016. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Mervyn Maze, MD, MB ChB has been a Professor in the Departments of Anesthesia and Pain Medicine, Intensive Care at the University of California, San Francisco since 1988.http://www.anesthesiology.uci.edu/psh2014_maze.shtml He has also served as Professor and Chair at Imperial College London.

Maze was born in Cape Town, South Africa where he earned his Bachelor of Medicine and Bachelor of Surgery from University of Cape Town, South Africa. He is the creator of discoveries that has resulted in 16 patents including a series of discoveries linked Neuroprotection. Maze recently published a study relating to the effects of inhaled xenon on cerebral white matter damage in cardiac patients.http://jama.jamanetwork.com/article.aspx?articleid=2503174

Awards & Honors

Maze was awarded the Excellence in Research Award from the American Society of Anesthesiology in 2003http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1943580. He has also been awarded an Honorary Lifetime Membership in Israel Society of Anesthesiologists for contributions to Anesthesiology in Israel, 2012

References

1. Mervy Maze, MD, MB, ChBhttp://www.anesthesiology.uci.edu/psh2014_maze.shtml

2. Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arresthttp://jama.jamanetwork.com/article.aspx?articleid=2503174